Evidence map›Paper›PMID 30001345›Full record

ArticlePloS one2018

Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: A multicentre, prospective, intervention study.

Elisabetta Caselli, Silvio Brusaferro, Maddalena Coccagna, Luca Arnoldo, Filippo Berloco, Paola Antonioli, Rosanna Tarricone, Gabriele Pelissero, Silvano Nola, Vincenza La Fauci and 6 more

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Risk analysis approaches for microbial ingredients in microbial-based cleaning products.Risk analysis : an official publication of the Society for Risk Analysis · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Elisabetta CaselliSection of Microbiology and Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.ORCID 0000-0001-6048-9141
Silvio BrusaferroDepartment of Medicine, University of Udine, Udine, Italy.
Maddalena CoccagnaCIAS Interdepartmental Research Centre, Departments of Medical Sciences and Architecture, University of Ferrara, Ferrara, Italy.
Luca ArnoldoDepartment of Medicine, University of Udine, Udine, Italy.
Filippo BerlocoFondazione Policlinico Universitario Agostino Gemelli, Roma, Italy.
Paola AntonioliDepartment of Infection Prevention Control and Risk Management, S. Anna University Hospital, Ferrara, Italy.ORCID 0000-0002-1257-3434
Rosanna TarriconeCentre for Research on Health and Social Care Management (CERGAS), Department of Policy Analysis and Public Management, Bocconi University, Milan, Italy.ORCID 0000-0002-2009-9357
Gabriele PelisseroDepartment of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
Silvano NolaAzienda USL di Ferrara, Ferrara, Italy.
Vincenza La FauciDepartment of Biomedical Sciences and Dental and Functional Images, University of Messina, Messina, Italy.
Alessandro ConteDepartment of Medicine, University of Udine, Udine, Italy.ORCID 0000-0003-2572-6556
Lorenzo TognonOspedale di Santa Maria del Prato, Feltre (Belluno), Italy.
Giovanni VilloneAzienda Ospedaliera Universitaria Ospedali Riuniti di Foggia, Foggia, Italy.
Nelso TruaOspedale Sant'Antonio Abate, Tolmezzo (Udine), Italy.ORCID 0000-0002-5293-402X
Sante MazzacaneCIAS Interdepartmental Research Centre, Departments of Medical Sciences and Architecture, University of Ferrara, Ferrara, Italy.ORCID 0000-0002-9018-7600
SAN-ICA Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Healthcare Associated Infections (HAI) are a global concern, further threatened by the increasing drug resistance of HAI-associated pathogens. On the other hand, persistent contamination of hospital surfaces contributes to HAI transmission, and it is not efficiently controlled by conventional cleaning, which does not prevent recontamination, has a high environmental impact and can favour selection of drug-resistant microbial strains. In the search for effective approaches, an eco-sustainable probiotic-based cleaning system (Probiotic Cleaning Hygiene System, PCHS) was recently shown to stably abate surface pathogens, without selecting antibiotic-resistant species. The aim of this study was to determine whether PCHS application could impact on HAI incidence. A multicentre, pre-post interventional study was performed for 18 months in the Internal Medicine wards of six Italian public hospitals (January 1st 2016-June 30th 2017). The intervention consisted of the substitution of conventional sanitation with PCHS, maintaining unaltered any other procedure influencing HAI control. HAI incidence in the pre and post-intervention period was the main outcome measure. Surface bioburden was also analyzed in parallel. Globally, 11,842 patients and 24,875 environmental samples were surveyed. PCHS was associated with a significant decrease of HAI cumulative incidence from a global 4.8% (284 patients with HAI over 5,930 total patients) to 2.3% (128 patients with HAI over 5,531 total patients) (OR = 0.44, CI 95% 0.35-0.54) (P<0.0001). Concurrently, PCHS was associated with a stable decrease of surface pathogens, compared to conventional sanitation (mean decrease 83%, range 70-96.3%), accompanied by a concurrent up to 2 Log drop of surface microbiota drug-resistance genes (P<0.0001; Pc = 0.008). Our study provides findings which support the impact of a sanitation procedure on HAI incidence, showing that the use of a probiotic-based environmental intervention can be associated with a significant decrease of the risk to contract a HAI during hospitalization. Once confirmed in larger experiences and other target populations, this eco-sustainable approach might be considered as a part of infection control and prevention (IPC) strategies. Trial registration-ISRCTN International Clinical Trials Registry, ISRCTN58986947.

Indexed as

ProbioticsSanitationAgedAged, 80 and overCross InfectionEnvironmental MicrobiologyFemaleHumansIncidenceItalyMaleMiddle AgedOutcome Assessment, Health CareProspective StudiesRisk Factors

Identifiers

PMID30001345
PMCPMC6042698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.